ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Opthea Ltd

Opthea Ltd (OPT)

2.25
0.01
(0.45%)
Closed July 29 4:00PM
2.25
0.00
(0.00%)
After Hours: 4:00PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
2.25
Bid
1.90
Ask
3.33
Volume
19,004
2.18 Day's Range 2.25
0.00 52 Week Range 0.00
Market Cap
Previous Close
2.24
Open
2.23
Last Trade
5
@
2.23
Last Trade Time
Financial Volume
$ 41,978
VWAP
2.2089
Average Volume (3m)
-
Shares Outstanding
82,850,861
Dividend Yield
-
PE Ratio
-0.24
Earnings Per Share (EPS)
-1.72
Revenue
12.69M
Net Profit
-142.52M

About Opthea Ltd

Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases. Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases.

Sector
Health & Allied Services,nec
Industry
Health & Allied Services,nec
Website
Headquarters
Melbourne, Victoria, Aus
Founded
1984
Opthea Ltd is listed in the Health & Allied Services sector of the NASDAQ with ticker OPT. The last closing price for Opthea was $2.24. Over the last year, Opthea shares have traded in a share price range of $ 0.00 to $ 0.00.

Opthea currently has 82,850,861 shares outstanding. The market capitalization of Opthea is $185.59 million. Opthea has a price to earnings ratio (PE ratio) of -0.24.

OPT Latest News

Shuttle Pharma’s Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONE

GAITHERSBURG, Md., July 19, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...

Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer

GAITHERSBURG, Md., June 18, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...

Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

GAITHERSBURG, Md., May 22, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving...

Shuttle Pharma Provides First Quarter 2024 Corporate Update

GAITHERSBURG, Md., May 14, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TWOU2U Inc
$ 2.70
(116.00%)
139.18M
LIPOLipella Pharmaceuticals Inc
$ 0.8576
(112.22%)
194.69M
NIPGNIP Group Inc
 16.50
(82.93%)
7.04M
TIVCTivic Health Systems Inc
$ 0.7049
(55.95%)
106.15M
ISPOInspirato Inc
$ 5.15
(47.99%)
6.24M
CGTXCognition Therapeutics Inc
$ 1.32
(-44.30%)
26.32M
GRIGRI Bio Inc
$ 0.8334
(-33.86%)
1.14M
CEROCERo Therapeutics Holdings Inc
$ 0.1817
(-29.02%)
8.28M
PRSTPresto Technologies Inc
$ 0.0499
(-26.51%)
29.32M
TGLTreasure Global Inc
$ 1.40
(-24.32%)
80.79k
NVDANVIDIA Corporation
$ 111.59
(-1.30%)
248.03M
LIPOLipella Pharmaceuticals Inc
$ 0.8576
(112.22%)
194.69M
SQQQProShares UltraPro Short QQQ
$ 9.05
(-0.55%)
152.03M
TWOU2U Inc
$ 2.70
(116.00%)
139.18M
TSLATesla Inc
$ 232.10
(5.60%)
129.2M